Skip to main content

Pharmacogenomics in the Preclinical Development of Vaccines

Evaluation of Efficacy and Systemic Toxicity in the Mouse Using Array Technology

  • Protocol
Pharmacogenomics in Drug Discovery and Development

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 448))

Summary

The development of vaccines, conventional protein based as well as nucleic acid based vaccines, and their delivery systems has been largely empirical and ineffective. This is partly due to a lack of methodology, since traditionally only a few markers are studied. By introducing gene expression analysis and bioinformatics into the design of vaccines and their delivery systems, vaccine development can be improved and accelerated considerably. Each vaccine antigen and delivery system combination is characterized by a unique genomic profile, a “fingerprint” that will give information of not only immunological and toxicological responses but also other related cellular responses e.g. cell cycle, apoptosis and carcinogenic effects. The resulting unique genomic fingerprint facilitates the establishment of molecular structure – pharmacological activity relationships and therefore leads to optimization of vaccine development.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gupta, R.K., Relyveld, E.H., Lindblad, E.B., Bizzini, B., Ben-Efraim, S., and Gupta, C.K. (1993) Adjuvants–a balance between toxicity and adjuvanticity. Vaccine. 11, 293–306.

    Article  CAS  PubMed  Google Scholar 

  2. Food and Drug Administration (FDA) Washington D.C. (1996) Preliminary guidelines for the manufacture and evaluation of DNA vaccines. Rockville, MD: Food and Drug Administration, Center for Biologics Evaluation and Research. Docket 96N-0400.

    Google Scholar 

  3. Bussiere, J.L., Mc Cormick, G.C., and Green, J.D. (1995) In Vaccine design: the subunit and adjuvant approach (M.F. Powell and M.J. Newman, eds.), Plenum Press, New York, pp. 61–79.

    Google Scholar 

  4. Regnström, K., Ragnarsson, E.G.E., Rydell, N., Sjöholm, I., and Artursson, P. (2002) Tetanus antigen modulates the gene expression profile of aluminum phosphate adjuvant in spleen lymphocytes in vivo. Pharmacogenomics J. 2, 57–64.

    Article  PubMed  Google Scholar 

  5. Regnström, K., Ragnarsson, E.G.E., and Artursson, P. (2003) Gene expression after vaccination of mice with formulations of diphtheria- or tetanus toxoid and different adjuvants: arrays identify shared immune response genes and vaccine-specific genes in spleen lymphocytes. Vaccine. 21, 2307–2317.

    Article  PubMed  Google Scholar 

  6. Regnström, K., Ragnarsson, E.G.E., Köping-Höggård, M., Torstensson, L., Nyblom, N., and Artursson, P. (2003) PEI–a potent, but not harmless, mucosal immunostimulator of mixed T-helper cell response and FasL mediated cell death in mice. Gene Ther. 10,1575–1583.

    Article  PubMed  Google Scholar 

  7. Regnström, K., Ragnarsson, E.G.E., Fryknäs, M., Köping-Höggård, M., and Artursson, P. (2006) Gene expression profiles in mouse lung tissue after administration of two cationic polymers used for non-viral gene delivery. Pharm. Res. 23, 475–482.

    Article  PubMed  Google Scholar 

  8. Bucy, R.P., Panoskaltsis-Mortari, A., Huang, G., et al. (1994) Heterogenicity of single cell cytokine gene expression in clonal T cell populations. J. Exp. Med. 180, 1251–1262.

    Article  CAS  PubMed  Google Scholar 

  9. Lazaridis, M. (2001) Course in statistical analysis of micro array studies. Presented at: Ninth International Conference on Intelligent Systems for Molecular Biology; Copenhagen; July.

    Google Scholar 

  10. Gieser, P., Bloom, G.C., and Lazaridis, E.N. (2002) Introduction to microarray experimentation and analysis, in Biostatistical methods (S. W. Looney, ed.), Methods in Molecular Biology, Humana Press, Totowa, NJ, 184:29–49.

    Chapter  Google Scholar 

  11. Teague, T.K., Hildeman, D., Kedl, R.M., et al. (1999) Activation changes the spectrum but not the diversity of genes expressed in T cells. Proc. Natl. Acad. Sci. U. S. A. 98, 12691–12696.

    Article  Google Scholar 

  12. Tamayo, P., Slonim, D., Mesirov, J., et al. (1999) Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc. Natl. Acad. Sci. U. S. A. 96, 2907–2912.

    Article  CAS  PubMed  Google Scholar 

  13. Eisen, M.B., Spellman, P.T., Brown, P.O., and Botstein, D. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U. S. A. 95, 14863–14868.

    Article  CAS  PubMed  Google Scholar 

  14. Bachmair, F., Huber, C.G., and Daxenbichler, G. (2002) Quantitation of gene expression by RT-PCR and HPLC analysis of PCR products, in Quantitative RT-PCR in RT-PCR protocols (J. O'Connell, ed.) Humana, Totowa, NJ, pp. 103–116.

    Chapter  Google Scholar 

  15. Jensen, T.K., Laegreid, A., Komorowski, J., and Hovig, E. (2001) A literature network of human genes for high-throughput analysis of gene expression. Nat. Genet. 28, 21–28.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Regnström, K.J. (2008). Pharmacogenomics in the Preclinical Development of Vaccines. In: Yan, Q. (eds) Pharmacogenomics in Drug Discovery and Development. Methods in Molecular Biology™, vol 448. Humana Press. https://doi.org/10.1007/978-1-59745-205-2_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-205-2_16

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-887-4

  • Online ISBN: 978-1-59745-205-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics